Balyasny Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-688,813
| Closed | -$1.2M | – | 1961 |
|
|
2018
Q2 | $1.2M | Sell |
688,813
-58,687
| -8% | -$102K | 0.01% | 904 |
|
|
2018
Q1 | $1.37M | Sell |
747,500
-927,500
| -55% | -$1.7M | 0.01% | 927 |
|
|
2017
Q4 | $3.74M | Buy |
1,675,000
+291,600
| +21% | +$650K | 0.01% | 773 |
|
|
2017
Q3 | $4.01M | Buy |
+1,383,400
| New | +$4.01M | 0.02% | 647 |
|
|
2016
Q3 | – | Sell |
-62,988
| Closed | -$239K | – | 1230 |
|
|
2016
Q2 | $239K | Sell |
62,988
-11,652
| -16% | -$44.2K | ﹤0.01% | 807 |
|
|
2016
Q1 | $206K | Sell |
74,640
-35,730
| -32% | -$98.6K | ﹤0.01% | 919 |
|
|
2015
Q4 | $626K | Buy |
110,370
+68,470
| +163% | +$388K | ﹤0.01% | 653 |
|
|
2015
Q3 | $222K | Buy |
41,900
+22,450
| +115% | +$119K | ﹤0.01% | 824 |
|
|
2015
Q2 | $161K | Buy |
+19,450
| New | +$161K | ﹤0.01% | 803 |
|